Barr Granted Summary Judgment On Another Patent In Allegra Challenge

Law360, New York (April 3, 2005, 12:00 AM EST) -- A federal court in New Jersey has granted summary judgment of non-infringement of one patent in generic maker Barr Pharmaceuticals Inc.'s patent challenge against Sanofi-Aventis’ Allegra allergy drug, Barr said.

In July, the U.S. District Court for the District of New Jersey granted Barr a summary judgment stating that the drug company did not infringe three other Allegra-D patents held by Aventis, now a part of European drug company Sanofi-Aventis SA.

Barr said the court has yet to rule on six other patents connected to the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.